Literature DB >> 10726956

Ecstasy-induced toxicity in rat liver.

G Beitia1, A Cobreros, L Sainz, E Cenarruzabeitia.   

Abstract

BACKGROUND/AIMS: The aim of the present study was to examine the effects of single and repeated administration of 3,4-methylenedioxyme-thamphetamine (MDMA, "ecstasy") on rat liver.
METHODS: Animals were given an acute (20 mg/kg) and repeated (20 mg/kg, b.i.d., for 4 consecutive days) intraperitoneal dose of MDMA, and at various times after administration the hepatic and serum determinations were made.
RESULTS: The effect of acute MDMA administration included increased triglyceride and cholesterol levels and an increase in all enzyme activities 6 h post administration. The toxic effect of MDMA was also observed in other hepatic processes. Glycogen content showed a marked decrease, which was accompanied by a decrease in serum glucose levels. No significant changes in lipid peroxidation and hepatic GSH content were observed. In contrast, multiple MDMA administration produced some evidence of oxidative stress, namely, increased MDA content and decreased GSH content, a small decrease in liver glycogen at 3 h recovering 6 h post dose, no effect on blood glucose and increased AST and ALP activities but no effects on ALT activity. Seven days after the last MDMA injection a tendency towards recovery was shown.
CONCLUSION: Our results show that the liver toxicity caused by MDMA administration involves several mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10726956     DOI: 10.1034/j.1600-0676.2000.020001008.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  13 in total

Review 1.  Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage.

Authors:  Byoung-Joon Song; Kwan-Hoon Moon; Vijay V Upreti; Natalie D Eddington; Insong J Lee
Journal:  Curr Pharm Biotechnol       Date:  2010-08       Impact factor: 2.837

2.  Chlorpromazine-induced hepatotoxicity during inflammation is mediated by TIRAP-dependent signaling pathway in mice.

Authors:  Adarsh Gandhi; Tao Guo; Pranav Shah; Bhagavatula Moorthy; Romi Ghose
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-11       Impact factor: 4.219

3.  Effects of repeated 3,4-methylenedioxymethamphetamine administration on neurotransmitter efflux and sensory-evoked discharge in the ventral posterior medial thalamus.

Authors:  M A Starr; M E Page; B D Waterhouse
Journal:  J Pharmacol Exp Ther       Date:  2011-10-07       Impact factor: 4.030

4.  Drug interaction between ethanol and 3,4-methylenedioxymethamphetamine ("ecstasy").

Authors:  Vijay V Upreti; Natalie D Eddington; Kwan-Hoon Moon; Byoung-Joon Song; Insong J Lee
Journal:  Toxicol Lett       Date:  2009-04-05       Impact factor: 4.372

5.  Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver.

Authors:  Kwan-Hoon Moon; Vijay V Upreti; Li-Rong Yu; Insong J Lee; Xiaoying Ye; Natalie D Eddington; Timothy D Veenstra; Byoung-Joon Song
Journal:  Proteomics       Date:  2008-09       Impact factor: 3.984

6.  Transient proximal tubular renal injury following Ecstasy ingestion.

Authors:  Charles Kwon; Arno Zaritsky; Vikas R Dharnidharka
Journal:  Pediatr Nephrol       Date:  2003-05-28       Impact factor: 3.714

7.  Induction of mitochondrial permeability transition (MPT) pore opening and ROS formation as a mechanism for methamphetamine-induced mitochondrial toxicity.

Authors:  Vida Mashayekhi; Mohammad Reza Eskandari; Farzad Kobarfard; Alireza Khajeamiri; Mir-Jamal Hosseini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-09-24       Impact factor: 3.000

8.  Oxidative stress in rat retina and hippocampus after chronic MDMA ('ecstasy') administration.

Authors:  María Miranda; Francisco Bosch-Morell; Siv Johnsen-Soriano; Jorge Barcia; Inmaculada Almansa; Samuel Asensio; Javier Araiz; Angel Messeguer; Francisco J Romero
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 4.414

9.  The effects of ecstasy on liver function tests, blood glucose, and lipids profile of male rats.

Authors:  Mohammad Reza Shahraki; Mahdieh Irani
Journal:  Int J High Risk Behav Addict       Date:  2014-09-17

10.  Expression of bax and bcl2 Genes in MDMA-induced Hepatotoxicity on Rat Liver Using Quantitative Real-Time PCR Method through Triggering Programmed Cell Death.

Authors:  Mitra Behroozaghdam; Mehrdad Hashemi; Gholamreza Javadi; Reza Mahdian; Mansoureh Soleimani
Journal:  Iran Red Crescent Med J       Date:  2015-11-26       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.